Overall Design Solution
The goal of our project is to engineer an HSV viral genome in the form of a bacterial artificial chromosome (BAC) to produce a customizable viral vector for many purposes. The original BAC that we acquired contains genes that are not ideal for our purpose, including Cre-LoxP recombination sites that are designed for animals or cells expressing Cre enzyme to excise the bacterial artificial chromosome sequence to reconstitute viral genome, as well as a beta-galactosidase gene used for selection marker in bacterial and mammalian cells. We would like to use the viral vector potentially with other viral vectors that utilize Cre-LoxP system, therefore an orthogonal system is preferred. In this case, the FRT-flp expression system was chosen. The FRT-flp system functions similarly to Cre-LoxP: the expression of the flp enzyme would delete the sequence flanked by two FRT sites. On the other hand, we would like to use the beta-gal gene as a selection marker for a different part of the genome; therefore, the gene needs to be knocked out. Secondly, the virus is inherently toxic to mammalian cells. The uncontrolled spread of the virus would be fatal. To control the toxicity, the thymidine kinase gene, a gene that is crucial to viral replication, will be replaced with a Tn7 DNA insertion site. The site would allow for the insertion of any DNA construct into the viral genome. The final design should be a new bacterial chromosome that can be customized as a gene delivery tool.
The first step of the modifications is to replace the LoxP sites, and the beta-gal gene with FRT sites. FRT sites allows for the excision of the bacterial artificial chromosome segments in the presence of enzyme flp.
The second modification replaces the toxic TK (thymidine kinase) gene with Tn7 insertion site and a kanamycin resistant selection marker. Tn7 site allows for the insertion of any DNA construct flanked by Tn7 Left and Tn7 Right sequence to be inserted precisely into the Tn7 site.